Create an account

Already have an account?
Technical support
Send
The password is: uppercase and lowercase English letters and numbers, no less than 6 characters
Submit

Login

Don’t have an account? Sign up
Forgot password?
Login
The AmoyDx® Super-ARMS ESR1 PCR Kit is a qualitative real-time PCR assay designed to detect 29 somatic mutations in the ESR1 gene across exons 4, 5, 6, 7, and 8 using circulating free DNA (cfDNA) extracted from plasma samples. cfDNA, derived from apoptotic and necrotic tumor cells, is detectable in the peripheral blood of breast cancer patients. Plasma-based detection of ESR1 mutations provides a non-invasive method for assessing mutation status, particularly in late-stage breast cancer cases, as cfDNA in early-stage patients is often more fragmented and present at lower concentrations.

 

Comprehensive ESR1 Gene Coverage


Covers 29 ESR1 mutations

Covers 29 ESR1 mutations

Limit of detection as low as 0.2%

Limit of detection
as low as 0.2%

Cost-efficient

Cost-efficient

Turnaround time within 5.5 hours

Turnaround time
within 5.5 hours

Specifications

Tests/kit
14
Instrument
QuantStudio5, SLAN-96S
Sample type
cfDNA extracted from plasma sample

Technology

Super-ARMS® represents an advancement over traditional ARMS technology achieved through enhanced primer and probe design.
With Super-ARMS, efficient amplification occurs when the 3’ base of the primer perfectly matches the mutant template. Conversely, if the 3’ base mismatches with the wild-type template, amplification efficiency is significantly reduced.

The refined primer design significantly enhances both specificity and sensitivity, offering improved performance in mutation detection.

Subscribe to our newsletter

Subscribe Now

Inquiry

Technical support
  • Technical support
  • Product Proposal
  • Information Consultant
  • Results Verification
  • Abnormal Results
  • Questioned Results
  • Other
Submit

Download

Don’t have an account? Sign up